These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6174255)

  • 1. Do asymptomatic, long term carriers of hepatitis B virus develop liver cancer?
    Munjal DD
    Clin Biochem; 1981 Dec; 14(6):316-8. PubMed ID: 6174255
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B virus and primary liver carcinoma: evidences for a filiation hepatitis B, cirrhosis and primary liver cancer.
    Maupas P; Coursaget P; Goudeau A; Drucker J; Sankale M; Linhard J; Diebolt G
    Ann Microbiol (Paris); 1977; 128(2):245-53. PubMed ID: 71006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early lesions and development of primary hepatocellular carcinoma in man--association with hepatitis B viral infection.
    Okita K; Kodama T; Harada T; Noda K; Fukumoto Y
    Gastroenterol Jpn; 1977; 12(2):51-7. PubMed ID: 70387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma: relation to alcohol, HB-antigen and alpha-fetoprotein.
    Dourdourekas D; Villa F; Szanto PB; Steigmann F
    Am J Gastroenterol; 1975 Apr; 63(4):307-11. PubMed ID: 48339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hepatocellular carcinoma.
    Hodgson HJ
    Br J Hosp Med; 1983 Mar; 29(3):240, 246, 250 passim. PubMed ID: 6191818
    [No Abstract]   [Full Text] [Related]  

  • 6. The detection of alpha-fetoprotein in HBs Ag and HBe Ag carriers.
    Panoyotopoulos S; Yiannacopoulos T; Margari-Papanicolaou P; Christou A
    Allergol Immunopathol (Madr); 1982; 10(1):1-4. PubMed ID: 6177229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic value of alpha-fetoprotein (AFP) in hepatocellular cancer in chronic carriers of HBsAg and positive HBeAg].
    Carrascosa D; Casado A; Ramírez MV; Sáez J
    Aten Primaria; 1996; 18(3):147-8. PubMed ID: 8768659
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum alpha fetoprotein in 714 mentally retarded carriers of hepatitis B surface antigen.
    Lohiya G; Lohiya S; Fischer T; Nguyen H; Vuu T; Humerez R
    Eur J Epidemiol; 1988 Jun; 4(2):181-4. PubMed ID: 2456944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of hepatocellular cancer during screening of 1125 patients with chronic hepatitis virus infection.
    Izzo F; Cremona F; Ruffolo F; Palaia R; Parisi V; Curley S
    J Chemother; 1997 Apr; 9(2):151-2. PubMed ID: 9176768
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis B (Australia) antigen--current clinical and epidemiological concepts.
    Patterson CP; Maynard JE; Berquist KR
    Ariz Med; 1974 Apr; 31(4):258-62. PubMed ID: 4364465
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatocellular carcinoma and correlations with virus B infection, alcoholism and other possible toxic agents: study of 76 cases].
    Giuliani-Piccari G; Spongano P; Formica G; Macchia S; Simoni S; Dal Monte PR
    G Clin Med; 1981 Feb; 62(2):103-11. PubMed ID: 6165640
    [No Abstract]   [Full Text] [Related]  

  • 12. Morbidity and mortality from chronic hepatitis B virus infection in family members of patients with malignant and nonmalignant hepatitis B virus-related chronic liver diseases.
    Lok AS; Lai CL; Chung HT; Lau JY; Leung EK; Wong LS
    Hepatology; 1991 May; 13(5):834-7. PubMed ID: 1709410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers.
    Lieberman HM; LaBrecque DR; Kew MC; Hadziyannis SJ; Shafritz DA
    Hepatology; 1983; 3(3):285-91. PubMed ID: 6301965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
    Liaw YF; Chu CM; Lin DY; Sheen IS; Yang CY; Huang MJ
    J Med Virol; 1984; 13(4):385-91. PubMed ID: 6330293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers.
    Liu CC; Wang YH; Chuang EY; Tsai MH; Chuang YH; Lin CL; Liu CJ; Hsiao BY; Lin SM; Liu LY; Yu MW
    Mol Carcinog; 2014 Jan; 53(1):58-66. PubMed ID: 22911910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological studies of alpha-fetoprotein and hepatitis B antigen in Tomié Town, Nagasaki, Japan.
    Koji T; Munehisa T; Yamaguchi K; Kusumoto Y; Nakamura S
    Ann N Y Acad Sci; 1975 Aug; 259():239-47. PubMed ID: 54026
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum ferritin and binding of serum ferritin to concanavalin A as a tumor marker in patients with primary liver cell cancer and chronic liver disease.
    Chapman RW; Bassendine MF; Laulicht M; Gorman A; Thomas HC; Sherlock S; Hoffbrand AV
    Dig Dis Sci; 1982 Feb; 27(2):111-6. PubMed ID: 6176407
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum alpha-fetoprotein (AFP) levels in liver cirrhosis and viral hepatitis cases].
    Imir T
    Mikrobiyol Bul; 1981 Jan; 15(1):7-13. PubMed ID: 6188026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for hepatocellular carcinoma].
    Leone N; Rizzetto M
    Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
    Stránský J; Zichová M; Vodák M
    Sb Lek; 1993; 94(4):311-5. PubMed ID: 7527585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.